| Year |
Citation |
Score |
| 2010 |
Chuang JC, Warner SL, Vollmer D, Vankayalapati H, Redkar S, Bearss DJ, Qiu X, Yoo CB, Jones PA. S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Molecular Cancer Therapeutics. 9: 1443-50. PMID 20442312 DOI: 10.1158/1535-7163.Mct-09-1048 |
0.766 |
|
| 2009 |
Jeong S, Liang G, Sharma S, Lin JC, Choi SH, Han H, Yoo CB, Egger G, Yang AS, Jones PA. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Molecular and Cellular Biology. 29: 5366-76. PMID 19620278 DOI: 10.1128/Mcb.00484-09 |
0.74 |
|
| 2009 |
Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK, Marquez VE, Jones PA. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Molecular Cancer Therapeutics. 8: 1579-88. PMID 19509260 DOI: 10.1158/1535-7163.Mct-09-0013 |
0.779 |
|
| 2009 |
Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics. 4: 176-84. PMID 19421002 DOI: 10.4161/Epi.4.3.8694 |
0.647 |
|
| 2008 |
Yoo CB, Chuang JC, Byun HM, Egger G, Yang AS, Dubeau L, Long T, Laird PW, Marquez VE, Jones PA. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prevention Research (Philadelphia, Pa.). 1: 233-40. PMID 19138966 DOI: 10.1158/1940-6207.Capr-07-0008 |
0.702 |
|
| 2008 |
Yoo CB, Valente R, Congiatu C, Gavazza F, Angel A, Siddiqui MA, Jones PA, McGuigan C, Marquez VE. Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine. Journal of Medicinal Chemistry. 51: 7593-601. PMID 19006382 DOI: 10.1021/Jm8005965 |
0.647 |
|
| 2008 |
Hother C, Cortez C, Miranda T, Yoo C, Workman C, Jones PA, Grønbæk K. 47 Upregulation of the miR-515 cluster in the MCF7 breast cancer cell line by epigenetic therapy Apmis. 116: 437-437. DOI: 10.1111/J.1600-0463.2008.00Abs1165_54.X |
0.381 |
|
| 2007 |
Yoo CB, Jeong S, Egger G, Liang G, Phiasivongsa P, Tang C, Redkar S, Jones PA. Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides. Cancer Research. 67: 6400-8. PMID 17616700 DOI: 10.1158/0008-5472.Can-07-0251 |
0.688 |
|
| 2006 |
Egger G, Jeong S, Escobar SG, Cortez CC, Li TW, Saito Y, Yoo CB, Jones PA, Liang G. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proceedings of the National Academy of Sciences of the United States of America. 103: 14080-5. PMID 16963560 DOI: 10.1073/Pnas.0604602103 |
0.76 |
|
| 2006 |
Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nature Reviews. Drug Discovery. 5: 37-50. PMID 16485345 DOI: 10.1038/Nrd1930 |
0.606 |
|
| 2006 |
Yoo CB, Jones PA. Erratum: Epigenetic therapy of cancer: past, present and future Nature Reviews Drug Discovery. 5: 170-170. DOI: 10.1038/Nrd1981 |
0.475 |
|
| 2005 |
Marquez VE, Kelley JA, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Annals of the New York Academy of Sciences. 1058: 246-54. PMID 16394141 DOI: 10.1196/Annals.1359.037 |
0.68 |
|
| 2005 |
Marquez VE, Barchi JJ, Kelley JA, Rao KV, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Nucleosides, Nucleotides & Nucleic Acids. 24: 305-18. PMID 16247946 DOI: 10.1081/Ncn-200059765 |
0.675 |
|
| 2005 |
Chuang JC, Yoo CB, Kwan JM, Li TW, Liang G, Yang AS, Jones PA. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Molecular Cancer Therapeutics. 4: 1515-20. PMID 16227400 DOI: 10.1158/1535-7163.Mct-05-0172 |
0.776 |
|
| 2004 |
Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7457-65. PMID 15569975 DOI: 10.1158/1078-0432.Ccr-04-0930 |
0.758 |
|
| 2004 |
Yoo CB, Cheng JC, Jones PA. Zebularine: a new drug for epigenetic therapy. Biochemical Society Transactions. 32: 910-2. PMID 15506921 DOI: 10.1042/Bst0320910 |
0.744 |
|
| 2004 |
Cheng JC, Yoo CB, Weisenberger DJ, Chuang J, Wozniak C, Liang G, Marquez VE, Greer S, Orntoft TF, Thykjaer T, Jones PA. Preferential response of cancer cells to zebularine. Cancer Cell. 6: 151-8. PMID 15324698 DOI: 10.1016/J.Ccr.2004.06.023 |
0.774 |
|
| 2004 |
Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, Gonzales FA, Jones PA. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proceedings of the National Academy of Sciences of the United States of America. 101: 7357-62. PMID 15123803 DOI: 10.1073/Pnas.0401866101 |
0.71 |
|
| Show low-probability matches. |